Monitoring the Session

SB 926

insurers can steer patients with lower copays

Became law, effective Sep 1, 2025

Verdict: No flags

No flagsInitial review
Sen. Kelly HancockRSenate 9

Initial review · graded Oct 20, 2026 · Headline, summary and grade are analysis of the bill text, not a finding about any person · How we grade

Caption

relating to certain practices of health benefit plan issuers to encourage the use of certain physicians and health care providers and rank physicians.

Caption from analyzed text · version I.

Summary

Steering and tiering must mainly benefit the patient or plan holder.

The bill lets HMOs and insurers use lower deductibles, copays, or other cost-sharing to steer patients toward certain doctors and providers. When they steer patients or sort doctors into tiers, they must do it mainly for the benefit of the patient or the plan holder. It also rewrites the rules for ranking doctors: plans must use standards from groups the insurance commissioner approves, give doctors 45 days' notice and a simple way to flag errors, and fix proven errors within 30 days, while the old formal reconsideration hearing is dropped.

Receipt

The receipt

89R-SB926 · 2025-01-24

SOLD BY

+ 1 coauthor

ITEM

relating to certain practices of health benefit plan issuers to encourage the use of certain physicians and health care providers and rank physicians.

WHAT IT DOES

Steering and tiering must mainly benefit the patient or plan holder.

The bill lets HMOs and insurers use lower deductibles, copays, or other cost-sharing to steer patients toward certain doctors and providers. When they steer patients or sort doctors into tiers, they must do it mainly for the benefit of the patient or the plan holder. It also rewrites the rules for ranking doctors: plans must use standards from groups the insurance commissioner approves, give doctors 45 days' notice and a simple way to flag errors, and fix proven errors within 30 days, while the old formal reconsideration hearing is dropped.

CHARGES

[ ] NONE FOUND

TOTAL

No significant fiscal implication to the State is anticipated.

LBB estimate · fiscal note version E · source

Sources

Fiscal note · version E · April 22, 2025

No first-year general revenue figure available here.

LBB published estimates · flow over the stated periods.

Source snapshot 2026-10-19, Central time.

HISTORY

  1. Received by the Secretary of the Senate
  2. Filed
  3. Read first time
  4. Referred to Health & Human Services
  5. Scheduled for public hearing on . . .
  6. Considered in public hearing
  7. Testimony taken in committee
  8. Left pending in committee
  9. Considered in public hearing
  10. Vote taken in committee
  11. Reported favorably as substituted
  12. Recommended for local & uncontested calendar
  13. Committee report printed and distributed
  14. Co-author authorized
  15. Placed on intent calendar
  16. Rules suspended-Regular order of business
  17. Read 2nd time
  18. Amendment(s) offered FA1 Hancock
  19. Amended
  20. Vote recorded in Journal
  21. Passed to engrossment as amended
  22. Vote recorded in Journal
  23. Three day rule suspended
  24. Record vote
  25. Read 3rd time
  26. Passed
  27. Record vote
  28. Reported engrossed
  29. Received from the Senate
  30. Read first time
  31. Referred to Insurance
  32. Considered in public hearing
  33. Reported favorably w/o amendment(s)
  34. Comte report filed with Committee Coordinator
  35. Committee report distributed
  36. Committee report sent to Calendars
  37. Considered in Calendars
  38. Considered in Calendars
  39. Placed on General State Calendar
  40. Read 2nd time
  41. Passed to 3rd reading
  42. Record vote RV#3757
  43. Statement(s) of vote recorded in Journal
  44. Read 3rd time
  45. Passed
  46. Record vote RV#3870
  47. Statement(s) of vote recorded in Journal
  48. House passage reported
  49. Reported enrolled
  50. Signed in the Senate
  51. Signed in the House
  52. Sent to the Governor
  53. Signed by the Governor
  54. Effective on 9/1/25
FILED UNDER

No verified beat found.

SIGNED FOR BY

House · 138 yea · 0 nay

Senate · 31 yea · 0 nay

Sources

House: Final passage · May 28, 2025. Journal. Published stock for this vote. Snapshot 2026-10-19, Central time.

Senate: Final passage · Apr 16, 2025. Journal. Published stock for this vote. Snapshot 2026-10-19, Central time.

All floor motions and other positions below.

No flags

THANK YOU FOR CHECKING THE RECEIPT

CAMPAIGN PAID FOR BY

CAMPAIGN PAID FOR BY

Donors

Stephen Brauer JR$57,791
Texans for Lawsuit Reform PAC$14,750
Q Political Action Committee$12,500

Top donors to Texans for Kelly Hancock SPAC during his Senate service. Not tied to this bill.

Sources

Gifts to Texans for Kelly Hancock SPAC dated July 1, 2024 to June 18, 2025, while he served in the Senate.

Derived from itemized gifts. State data as of Nov 4, 2026.

Money

Missing data does not establish zero giving. Display amounts are rounded.

Votes5

House May 28, 2025

Yea
138
Nay
0
Present, not voting
1
Absent
4
Excused
7
Names

Named positions matched to lawmakers. See the journal for unmatched names.

House journal

Sources

Record 3870

SB 926 was passed by (Record 3870): 138 Yeas, 0 Nays, 1 Present, not voting.

Published stock of positions for this vote, except where marked derived.

  • Yea: 138 (published)
  • Nay: 0 (published)
  • Present, not voting: 1 (published)
  • Absent: 4 (derived from named list)
  • Excused: 7 (derived from named list)

House journal. Source snapshot 2026-10-19, Central time.

House May 27, 2025

Yea
132
Nay
0
Present, not voting
1
Absent
15
Excused
2
Names

Named positions matched to lawmakers. See the journal for unmatched names.

House journal

Sources

Record 3757

SB 926 was passed to third reading by (Record 3757): 132 Yeas, 0 Nays, 1 Present, not voting.

Published stock of positions for this vote, except where marked derived.

  • Yea: 132 (published)
  • Nay: 0 (published)
  • Present, not voting: 1 (published)
  • Absent: 15 (derived from named list)
  • Excused: 2 (derived from named list)

House journal. Source snapshot 2026-10-19, Central time.

Senate Apr 16, 2025

Yea
31
Nay
0
Present, not voting
Not printed
Absent
Not printed
Excused
Not printed
Names

Senate journal

Names were not printed. No individual positions are inferred.

Sources

Senator Hancock moved that Senate Rule 7.18 and the Constitutional Rule requiring bills to be read on three several days be suspended and that CSSB 926 be placed on its third reading and final passage. The motion prevailed by the following vote: Yeas 31, Nays 0. The bill was read third time and was passed by the following vote: Yeas 31, Nays 0.

Published stock of positions for this vote, except where marked derived.

  • Yea: 31 (published)
  • Nay: 0 (published)
  • Present, not voting: Not printed
  • Absent: Not printed
  • Excused: Not printed

Senate journal. Source snapshot 2026-10-19, Central time.

Senate Apr 16, 2025

Yea
31
Nay
0
Present, not voting
Not printed
Absent
Not printed
Excused
Not printed
Names

Senate journal

Names were not printed. No individual positions are inferred.

Sources

Senator Hancock moved that Senate Rule 7.18 and the Constitutional Rule requiring bills to be read on three several days be suspended and that CSSB 926 be placed on its third reading and final passage. The motion prevailed by the following vote: Yeas 31, Nays 0.

Published stock of positions for this vote, except where marked derived.

  • Yea: 31 (published)
  • Nay: 0 (published)
  • Present, not voting: Not printed
  • Absent: Not printed
  • Excused: Not printed

Senate journal. Source snapshot 2026-10-19, Central time.

Senate Apr 16, 2025

Yea
Not printed
Nay
Not printed
Present, not voting
Not printed
Absent
Not printed
Excused
Not printed
Names

Senate journal

Names were not printed. No individual positions are inferred.

Voice vote. No numeric tally or individual yeas are inferred.

Sources

CSSB 926 as amended was passed to engrossment by a viva voce vote.

Published stock of positions for this vote, except where marked derived.

  • Yea: Not printed
  • Nay: Not printed
  • Present, not voting: Not printed
  • Absent: Not printed
  • Excused: Not printed

Senate journal. Source snapshot 2026-10-19, Central time.

Witnesses17
For
14
Against
1
On
2
Names

For

  • AARP Texas1 registration
  • Blue Cross and Blue Shield of Texas1 registration
  • Denniston Data, Inc1 registration
  • Foundation for Research on Equal Opportunity1 registration
  • Self; Americans for Prosperity1 registration
  • Self; Americans for Prosperity, Texas1 registration
  • Self; Texas Association of Benefit Administrators1 registration
  • Self; Texas Public Policy Foundation1 registration
  • Texans for Affordable Healthcare1 registration
  • Texas 20361 registration
  • Texas Academy of Family Physicians1 registration
  • Texas Association of Business1 registration
  • Texas Association of Health Plans1 registration
  • Texas Employers for Affordable Healthcare1 registration

Against

  • Self1 registration

On

  • Self; Texas Medical Association1 registration
  • TDI1 registration
Sources

17 parsed registrations across the loaded witness lists.

Derived stock of witness registrations. Repeated appearances count separately. Organizations and self-representation appear as printed.

Senate witness list. Source snapshot 2026-10-20, Central time.

Fiscal

No significant fiscal implication to the State is anticipated.

LBB estimate · fiscal note version E · source

Sources

Fiscal note · version E · April 22, 2025

No first-year general revenue figure available here.

LBB published estimates · flow over the stated periods.

Source snapshot 2026-10-19, Central time.

How this was graded

Analysis of text version I by claude-opus-5-5, Oct 20, 2026, against the published rubric.

Sources

Texas Senate · Filed Jan 24, 2025

06/20/2025 E Effective on 9/1/25

Texas Legislature Online · Introduced · Senate Committee Report · Engrossed · House Committee Report · Enrolled

Data snapshot Oct 26, 2026 at 4:20 AM CDT. Grades, charges, quotes and corrections follow the published record.

Coauthors
Sponsors

House committee · Insurance · Committee vote 8 aye, 0 nay, 1 absent · Out of committee

Senate committee · Health & Human Services · Committee vote 9 aye, 0 nay · Out of committee

Companion

HB 1959 by Frank (identical)

Subjects

Health Care Providers

Insurance--Health & Accident

HEALTH MAINTENANCE ORGANIZATIONS

PHYSICIANS

INSURANCE, COMMISSIONER OF

Text

The text as introduced · 1,172 words

89R7882 DNC-F

By: Hancock
S.B. No. 926

A BILL TO BE ENTITLED

AN ACT

relating to certain practices of health benefit plan issuers to

encourage the use of certain physicians and health care providers

and rank physicians.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. Subchapter I, Chapter 843, Insurance Code, is

amended by adding Section 843.322 to read as follows:

Sec. 843.322. INCENTIVES TO USE CERTAIN PHYSICIANS OR

PROVIDERS. (a) A health maintenance organization may provide

incentives for enrollees to use certain physicians or providers

through modified deductibles, copayments, coinsurance, or other

cost-sharing provisions.

(b) A health maintenance organization that encourages an

enrollee to obtain a health care service from a particular

physician or provider, including offering incentives to encourage

enrollees to use specific physicians or providers, or that

introduces or modifies a tiered network plan or assigns physicians

or providers into tiers, has a fiduciary duty to the enrollee or

group contract holder to engage in that conduct only for the primary

benefit of the enrollee or group contract holder.

SECTION 2. Section 1301.0045(a), Insurance Code, is amended

to read as follows:

(a) Except as provided by Sections [ Section ] 1301.0046 and

1301.0047 , this chapter may not be construed to limit the level of

reimbursement or the level of coverage, including deductibles,

copayments, coinsurance, or other cost-sharing provisions, that

are applicable to preferred providers or, for plans other than

exclusive provider benefit plans, nonpreferred providers.

SECTION 3. Subchapter A, Chapter 1301, Insurance Code, is

amended by adding Section 1301.0047 to read as follows:

Sec. 1301.0047. INCENTIVES TO USE CERTAIN PHYSICIANS OR

HEALTH CARE PROVIDERS. (a) An insurer may provide incentives for

insureds to use certain physicians or health care providers through

modified deductibles, copayments, coinsurance, or other

cost-sharing provisions.

(b) An insurer that encourages an insured to obtain a health

care service from a particular physician or health care provider,

including offering incentives to encourage insureds to use specific

physicians or providers, or that introduces or modifies a tiered

network plan or assigns physicians or providers into tiers, has a

fiduciary duty to the insured or policyholder to engage in that

conduct only for the primary benefit of the insured or

policyholder.

SECTION 4. Section 1460.003, Insurance Code, is amended by

amending Subsection (a) and adding Subsection (a-1) to read as

follows:

(a) A health benefit plan issuer, including a subsidiary or

affiliate, may not rank physicians or [ , ] classify physicians into

tiers based on performance[ , or publish physician-specific

information that includes rankings, tiers, ratings, or other

comparisons of a physician's performance against standards,

measures, or other physicians, ] unless:

(1) the standards used by the health benefit plan

issuer to rank or classify are propagated or developed by an

organization designated by the commissioner through rules adopted

under Section 1460.005;

(2) the ranking, comparison, or evaluation:

(A) is disclosed to each affected physician at

least 45 days before the date the ranking, comparison, or

evaluation is released, published, or distributed to enrollees by

the health benefit plan issuer; and

(B) identifies which products or networks

offered by the health benefit plan issuer the ranking, comparison,

or evaluation will be used for; and

(3) each affected physician is given an easy-to-use

process to identify discrepancies between the standards and the

ranking, comparison, or evaluation as propagated by the health

benefit plan issuer [ the standards used by the health benefit plan

issuer conform to nationally recognized standards and guidelines as

required by rules adopted under Section 1460.005;

[ (2) the standards and measurements to be used by the

health benefit plan issuer are disclosed to each affected physician

before any evaluation period used by the health benefit plan

issuer; and

[ (3) each affected physician is afforded, before any

publication or other public dissemination, an opportunity to

dispute the ranking or classification through a process that, at a

minimum, includes due process protections that conform to the

following protections:

[ (A) the health benefit plan issuer provides at

least 45 days' written notice to the physician of the proposed

rating, ranking, tiering, or comparison, including the

methodologies, data, and all other information utilized by the

health benefit plan issuer in its rating, tiering, ranking, or

comparison decision;

[ (B) in addition to any written fair

reconsideration process, the health benefit plan issuer, upon a

request for review that is made within 30 days of receiving the

notice under Paragraph (A), provides a fair reconsideration

proceeding, at the physician's option:

[ (i) by teleconference, at an agreed upon

time; or

[ (ii) in person, at an agreed upon time or

between the hours of 8:00 a.m. and 5:00 p.m. Monday through Friday;

[ (C) the physician has the right to provide

information at a requested fair reconsideration proceeding for

determination by a decision-maker, have a representative

participate in the fair reconsideration proceeding, and submit a

written statement at the conclusion of the fair reconsideration

proceeding; and

[ (D) the health benefit plan issuer provides a

written communication of the outcome of a fair reconsideration

proceeding prior to any publication or dissemination of the rating,

ranking, tiering, or comparison. The written communication must

include the specific reasons for the final decision ].

(a-1) If a physician submits information to a health benefit

plan issuer under Subsection (a)(3) sufficient to establish a

discrepancy, the health benefit plan issuer must remedy the

discrepancy by the later of:

(1) publication; or

(2) the 30th day after the date the health benefit plan

issuer receives the information.

SECTION 5. Section 1460.005(c), Insurance Code, is amended

to read as follows:

(c) In adopting rules under this section, the commissioner

may only designate [ shall consider the standards, guidelines, and

measures prescribed by nationally recognized ] organizations that

meet the following requirements:

(1) the prescribing organization is bona fide and

unbiased toward or against any medical provider;

(2) the standards to be used in rankings, comparisons,

or evaluations:

(A) are nationally recognized, or based on

expert-provider consensus or leading clinical evidence-based

scholarship;

(B) have a publicly transparent methodology; and

(C) if based on clinical outcomes, are

risk-adjusted; and

(3) the prescribing organization has an easy-to-use

process by which a medical provider may report data, evidentiary,

factual, or mathematical errors for prompt investigation and, if

appropriate, correction [ establish or promote guidelines and

performance measures emphasizing quality of health care, including

the National Quality Forum and the AQA Alliance. If neither the

National Quality Forum nor the AQA Alliance has established

standards or guidelines regarding an issue, the commissioner shall

consider the standards, guidelines, and measures prescribed by the

National Committee on Quality Assurance and other similar national

organizations. If neither the National Quality Forum, nor the AQA

Alliance, nor other national organizations have established

standards or guidelines regarding an issue, the commissioner shall

consider standards, guidelines, and measures based on other bona

fide nationally recognized guidelines, expert-based physician

consensus quality standards, or leading objective clinical

evidence and scholarship ].

SECTION 6. This Act takes effect September 1, 2025.